Showing results (3131-3140 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|May 10, 2020
Randomized Phase II Study of First-Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non-Small Cell Lung Cancer: LOGIK0801Koichi Takayama, Masafumi Takeshita, Koji Inoue, et al.The Oncologist|June 11, 2020
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical TrialJorg Dietrich, Laura Versmee, Jan Drappatz, et al.The Oncologist|September 12, 2021
Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological DistressDaisuke Arai, Takashi Sato, Ichiro Nakachi, et al.The Oncologist|November 11, 2022
Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with CancerJegy M Tennison, Arash Asher, David Hui, et al.The Oncologist|September 13, 2021
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 TrialLori J Wirth, Bruce Robinson, Valentina Boni, et al.The Oncologist|September 13, 2021
BRAF V600E Mediates Crizotinib Resistance and Responds to Dabrafenib and Trametinib in a ROS1-Rearranged Non-Small Cell Lung Cancer: A Case ReportJuan Li, Qifeng Wang, Jun Ge, et al.The Oncologist|September 10, 2021
Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic AdenocarcinomaEvan J Walker, Dena Goldberg, Kelly M Gordon, et al.The Oncologist|February 10, 2023
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other EtiologiesSurendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, et al.Pageof 571